Tamr partners with Accenture to tackle data challenges in drug discovery

Tamr Inc. has officially joined Accenture‘s open partner ecosystem, a strategic collaboration designed to enhance efforts in drug discovery and patient outcomes. This initiative aims to connect independent software vendors (ISVs) and life sciences companies, facilitating more effective partnerships. Through this ecosystem, Accenture is integrating cutting-edge technologies, including Tamr’s proprietary data unification software, into its cloud-based informatics research platform. The goal is to address the critical challenges in data management that can hinder progress in drug discovery.

Accenture’s research platform is a vital tool for life sciences organizations, providing a cloud-based environment to streamline research, improve productivity, and foster innovation in drug discovery. By adding Tamr’s technology, Accenture seeks to help life sciences companies overcome complex data unification issues. These problems often create significant bottlenecks in digital transformation initiatives. With Tamr’s Unify, a machine learning-powered data unification platform, researchers can automate the integration of various data sources. This will enable them to bypass time-consuming data processing tasks and focus more on analytics, insights, and discovery.

Innovation-driven by open partnerships

Joe Donahue, managing director at Accenture’s Life Sciences practice, emphasized the importance of the open partner ecosystem in driving innovation for Accenture’s clients. He noted that Tamr’s integration into the ecosystem will provide users with an efficient solution to the data variety challenge, which often impedes progress. By eliminating the need for manual data preparation, researchers will have more time to focus on analyzing data and uncovering valuable insights, ultimately contributing to better patient outcomes.

For Tamr, the collaboration represents a significant step in addressing one of the most persistent challenges in digital transformation: data unification. Toffer Winslow, Tamr’s chief business officer, highlighted the widespread challenge of unifying diverse data sources and ensuring timely, high-quality data delivery. By partnering with Accenture, Tamr aims to alleviate these obstacles, empowering life sciences researchers to optimize the drug discovery process and accelerate breakthroughs in medicine.

The collaboration between Tamr and Accenture underscores the increasing importance of data-driven solutions in life sciences and their role in transforming research workflows. With this partnership, both companies are positioned to make substantial contributions to the future of drug discovery and patient care.